Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuropace, Inc. - Common Stock (NQ:NPCE)

10.76 +0.19 (+1.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 324,074
Open 10.50
Bid (Size) 9.950 (9)
Ask (Size) 10.93 (1)
Prev. Close 10.57
Today's Range 10.20 - 10.90
52wk Range 5.450 - 18.98
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-7.1%
-7.1%
1 Month
-15.0%
-15.0%
3 Month
-11.3%
-11.3%
6 Month
-3.4%
-3.4%
1 Year
+60.8%
+60.8%

More News

Read More
NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Analyst Expectations For NeuroPace's Future
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Here are the top movers in Tuesday's session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
Dow Surges Over 600 Points; US Durable Goods Orders Fall in April
Via Benzinga
Topics Stocks
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings
Via Benzinga
Tower Semiconductor Posts Upbeat Earnings, Joins Nutex Health, Kornit Digital, Tencent Music Entertainment And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Earnings Scheduled For May 13, 2025
Via Benzinga
Kura Sushi Posts Downbeat Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting
From NeuroPace, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Neuropace, Inc. - Common Stock publicly traded?
Yes, Neuropace, Inc. - Common Stock is publicly traded.
What exchange does Neuropace, Inc. - Common Stock trade on?
Neuropace, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neuropace, Inc. - Common Stock?
The ticker symbol for Neuropace, Inc. - Common Stock is NPCE on the Nasdaq Stock Market
What is the current price of Neuropace, Inc. - Common Stock?
The current price of Neuropace, Inc. - Common Stock is 10.76
When was Neuropace, Inc. - Common Stock last traded?
The last trade of Neuropace, Inc. - Common Stock was at 06/24/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.